Parallel trade in pharmaceuticals is a mature and developed business but continues to challenge manufacturers. Although the overall level of trade within the EEA is broadly stable at around 5% of sales, the underlying dynamics are turbulent with continuing exchange rate uncertainty, increasing fragmentation with many different types of products affected and BREXIT on the horizon. Pharmaceutical and device manufacturers now recognise it is a cross-departmental effort to ensure business integrity. This workshop will educate attendees on the following:
• Challenges of logistics and supply
• Challenges of data availability and accuracy
• Internal issues and resolution
• Revenue and profit
• Ensuring patient supply